Indocyanine Green (ICG) angiography involves injection of a dark green dye into a peripheral vein, and use of a special camera to image the choroidal circulation. This is normally invisible during fluorescein angiography.
The dye is registered for use by the Therapeutic Goods Administration, but the cost is not subsidised by the Pharmaceutical Benefits Scheme (PBS). This means that the government does not pay for the drug, and you will therefore be responsible for the cost: we only charge patients what it costs us to buy the drug (ie we do not make a profit selling the drug to you).
ICG is particularly useful in inflammatory eye disease, and is also useful in patients with age-related macular degeneration.
ICG is a very safe drug, and the chance of serious adverse effects is very low. The chance of death caused by ICG administration is less than 1 in 300,000.
You must inform us if you have any allergies, particularly to seafood or Iodine-containing compounds. You cannot have ICG if you are pregnant.